These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 12073883)
1. Eptastigmine, nicotinamide and nicotinic acid determination using an inhibition enzyme sensor; application to pharmaceutical analysis. Campanella L; Cocco R; Favero G; Sammartino MP; Tomassetti M Ann Chim; 2002 Apr; 92(4):373-85. PubMed ID: 12073883 [TBL] [Abstract][Full Text] [Related]
2. Determination of compounds with anticholinesterase activity in commercial drugs by a new enzyme sensor. Campanella L; Cocco R; Tomassetti M J Pharm Biomed Anal; 1992; 10(10-12):741-9. PubMed ID: 1298377 [TBL] [Abstract][Full Text] [Related]
3. Determination of physostigmine and pyridostigmine in pharmaceutical formulations by capillary electrophoresis. Havel J; Patocka J; Bocaz G J Capill Electrophor Microchip Technol; 2002; 7(5-6):107-12. PubMed ID: 12546159 [TBL] [Abstract][Full Text] [Related]
4. Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow-metabolism ratio of normal rats. Scremin OU; Scremin AM; Heuser D; Hudgell R; Romero E; Imbimbo BP J Cereb Blood Flow Metab; 1993 Jul; 13(4):702-11. PubMed ID: 8314923 [TBL] [Abstract][Full Text] [Related]
5. Rapid potentiometric determination of cholinesterases in plasma and red cells: application to eptastigmine monitoring. Cazzola E; Lattuada N; Zecca L; Radice D; Luzzana M; Imbimbo BP; Auteri A; Mosca A Chem Biol Interact; 1993 Jun; 87(1-3):265-8. PubMed ID: 8343985 [TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics and pharmacokinetics of eptastigmine in elderly subjects. Auteri A; Mosca A; Lattuada N; Luzzana M; Zecca L; Radice D; Imbimbo BP Eur J Clin Pharmacol; 1993; 45(4):373-6. PubMed ID: 8299673 [TBL] [Abstract][Full Text] [Related]
7. Anticholinesterase activity measurement by a choline biosensor: application in water analysis. Bernabei M; Chiavarini S; Cremisini C; Palleschi G Biosens Bioelectron; 1993; 8(5):265-71. PubMed ID: 8398050 [TBL] [Abstract][Full Text] [Related]
8. Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group. Canal N; Imbimbo BP Clin Pharmacol Ther; 1996 Aug; 60(2):218-28. PubMed ID: 8823240 [TBL] [Abstract][Full Text] [Related]
9. Relationship between pharmacokinetics and pharmacodynamics of eptastigmine in young healthy volunteers. Imbimbo BP; Licini M; Schettino M; Mosca A; Onelli E; Zecca L; Giustina A J Clin Pharmacol; 1995 Mar; 35(3):285-90. PubMed ID: 7608318 [TBL] [Abstract][Full Text] [Related]
10. Microcalorimetric study of the inhibition of butyrylcholinesterase by carbamates. Debord J; Laubarie C; Dantoine T Anal Biochem; 2008 Feb; 373(2):247-52. PubMed ID: 17950687 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic monitoring of eptastigmine in capillary blood. Mosca A; Ghezzi A; Luzzana M; Paleari R; Imbimbo BP Eur J Clin Pharmacol; 1996; 50(5):425-7. PubMed ID: 8839668 [No Abstract] [Full Text] [Related]
12. Inhibition of acetylcholinesterase by new physostigmine derivatives. Marta M; Pomponi M Biomed Biochim Acta; 1988; 47(3):285-8. PubMed ID: 3178795 [TBL] [Abstract][Full Text] [Related]
13. Excessive nicotinic acid increases methyl consumption and hydrogen peroxide generation in rats. Li D; Luo N; Ma Q; Li SZ; Shi Q; Cao Y; Zhou SS Pharm Biol; 2013 Jan; 51(1):8-12. PubMed ID: 22971213 [TBL] [Abstract][Full Text] [Related]
14. [STUDY OF THE ANTICHOLINESTERASE ACTIVITY OF THE NICOTINIC ESTER OF DIETHYLAMINOETHANOL]. ROYER R; LAMARCHE M; DALICHAMPS P C R Seances Soc Biol Fil; 1963; 157():2048-50. PubMed ID: 14115657 [No Abstract] [Full Text] [Related]
15. Maximum tolerated dose and pharmacodynamics of eptastigmine in elderly healthy volunteers. Mant T; Troetel WM; Imbimbo BP J Clin Pharmacol; 1998 Jul; 38(7):610-7. PubMed ID: 9702845 [TBL] [Abstract][Full Text] [Related]
16. Eptastigmine improves eight-arm radial maze performance in aged rats. Braida D; Ottonello F; Sala M Pharmacol Res; 2000 Oct; 42(4):299-304. PubMed ID: 10987987 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities. Zhan ZJ; Bian HL; Wang JW; Shan WG Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867 [TBL] [Abstract][Full Text] [Related]
18. Phosphotriesterase, pralidoxime-2-chloride (2-PAM) and eptastigmine treatments and their combinations in DFP intoxication. Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O Toxicol Appl Pharmacol; 1996 Dec; 141(2):555-60. PubMed ID: 8975781 [TBL] [Abstract][Full Text] [Related]
19. [Studies on the preparation of sample solution for determination of nicotinic acid and nicotinamide in foods by high performance liquid chromatography]. Tsuji S; Koiguchi S; Narita M; Sarashi Y; Shibata T; Ito Y Eisei Shikenjo Hokoku; 1993; (111):107-11. PubMed ID: 7920547 [TBL] [Abstract][Full Text] [Related]
20. Excitatory and inhibitory effects of second-generation cholinesterase inhibitors on rat gastrointestinal transit. Braida D; Virag W; Ottonello F; Sala M Pharmacol Res; 2000 Jun; 41(6):671-7. PubMed ID: 10816338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]